Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 39Squamous Cell Carcinoma of Head and Neck 20Lung Neoplasms 20Oropharyngeal Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Endometrial Neoplasms 6Carcinoma 6Pancreatic Neoplasms 5Mouth Neoplasms 5Colorectal Neoplasms 5Cholangiocarcinoma 5Biliary Tract Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Squamous Cell 4Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2

Interventions

Platinum 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Immunoglobulin G 2Docetaxel 2Disulfides 2Carboplatin 2Bevacizumab 2dehydroftorafur 1atezolizumab 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Cetuximab 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoid Interstitial Pneumonia × Cisplatin × 30 days × Clear all
NCT05063552 2026-06-03

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
430 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡